MIOS and neoplasm: Using the Youden index to determine the optimal cut-off values defining high and low expression groups, it was found that patients with high expression of YULINK were at higher risk than those with low expression for large tumor size, TNM III + IV stages, multiple tumors, vascular invasion, relapse, and death.